•
Jun 30, 2023

Immix Biopharma Q2 2023 Earnings Report

EPS
-$0.24
Previous year: -$0.11
+118.2%
Cash and Equivalents
$12.7M
Previous year: $18.4M
-31.2%
Total Assets
$15.6M
Previous year: $19.1M
-18.4%

Immix Biopharma

Immix Biopharma